NDC 59762-1530-2 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-1530
- Requested NDC
- 59762-1530-2
- Package NDCs from labels
- 59762-1530-2
- Manufacturer
- RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited
- Effective date
- 2011-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited | RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited | 2011-08-03 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-1530-1 | EA - Each | 59762-1530 | 33f98858-6344-41d0-b915-1de2df042cb5 | 1 | 2012-07-24 |
| 59762-1530-2 | EA - Each | 59762-1530 | 8a32a6b4-a5fc-43e1-9f0b-8fa4525cb7bb | 1 | 2012-07-24 |
| 59762-1530-3 | EA - Each | 59762-1530 | 870fd041-5725-4d60-b332-1b412ec77377 | 1 | 2012-07-24 |
| 59762-1530-4 | EA - Each | 59762-1530 | 86429126-4c69-4d32-9aff-f6377ab760b9 | 1 | 2012-07-24 |
| 59762-1530-5 | EA - Each | 59762-1530 | b14b19c2-d0b3-4d43-8c7f-14f964865447 | 1 | 2012-07-24 |
| 59762-1530-6 | EA - Each | 59762-1530 | d3aebcb9-4905-4e50-8e8f-34b2e99e96cd | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| anhydrous dibasic calcium phosphate | INACTIVE INGREDIENT | L11K75P92J | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Cardinal Health 107, LLC | a74239bf-4684-424c-ba4e-6087e363265b | 2026-04-09 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Amneal Pharmaceuticals NY LLC | 856a8cdc-57cc-4355-966d-986bbc5fa6e6 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | 6f20efca-943b-4bc2-a157-0931bd4d4585 | 2026-03-28 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 5f7a4bd1-8083-46ca-95f2-e8c476b5367c | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | bed1710f-edd9-488d-855b-603d50ee212c | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | ff807933-7433-4f8c-9d09-02a57e51d0fc | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | ba6f6ab5-b65a-4486-b994-2d8bbbe650af | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | 5d7ca186-f22b-465f-913b-c020240b2c66 | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | 50112e22-5a69-47c9-90cd-82bbacae7418 | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | 9654e50b-811a-4c89-b1ab-f48418b204c1 | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | f16e04b5-57b9-49cc-811b-07d85ccb5d9f | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Legacy Pharmaceutical Packaging, LLC | 2cdd0da9-eea6-45e0-b0b7-35413a168a4f | 2026-03-03 | Warnings, Adverse reactions | 197361 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Legacy Pharmaceutical Packaging, LLC | 215ef2cb-d5b6-43d5-bbd5-195ec57cde2b | 2026-03-03 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aurobindo Pharma Limited | b6f298ba-2d7e-4a3c-9edb-8b60aba716d6 | 2026-03-03 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | b25681a9-7b0e-40f9-844e-ec4842e3713c | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 1df35c9b-0cd8-41f4-b9d4-8f51ba57b3e0 | 2026-02-26 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | a6635bb3-b8d5-4046-ac56-27af9bac877e | 2026-02-26 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | aec7618e-c9da-431f-8b6a-14aa399242f6 | 2026-02-25 | Warnings, Adverse reactions | 197361 864V2Q084H |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | ea9f44a1-96cf-496a-8c07-18d8de27e512 | 2026-02-25 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | 4e6bf47a-ee8a-4083-8cce-a6a25260d3fb | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.